Clinical Trial Update: Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial update reports completion of a study evaluating daratumumab in patients with muscle-invasive bladder cancer and metastatic renal cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Urothelial Carcinoma
• Clear Cell Renal Cell Carcinoma
• Muscle-invasive Bladder Cancer
• Renal Cell Carcinoma

Drugs mentioned

• DARZALEX (daratumumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma | EARLY_Phase 1 | Status: COMPLETED